- Supported exchanges /
- XETRA /
- PSG.XETRA
PharmaSGP Holding SE (PSG XETRA) stock market data APIs
PharmaSGP Holding SE manufactures and sells over-the-counter drugs and other healthcare products in Germany. The company's pharmaceutical products include Baldriparan for the treatment of sleep disorders; Spalt, Formigran, and Kamol massage creams for the treatment of various pain conditions; RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Revitensin, a drug for the treatment of hair loss; Dorisol for neuralgia (nerve pain), headaches, and migraines; Fulminan, a beauty drink; Lindaven, a pharmaceutical drops to treat their unpleasant problem; and SCLEROCALMAN, a drug for the treatment of clogged cerebral blood vessels. It also offers Prostacalman, a medication for cystitis and urination discomfort in a benign enlarged prostate; Revoten for women with weak connective tissue; Mindalin, a micronutrient drink for a healthy cardiovascular system; MELISTON, a prescription-free tablets to treat anxiety, restlessness, and mood swings; Deruba, a cream for skin redness; Lentisol that prevents the formation of new pigment spots; Neodolor, a headache tablet; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo. The company sells its products through pharmacies and wholesalers. It also exports its products to European countries comprising Austria, Italy, Belgium, Spain, and France. The company was founded in 2012 and is based in Gräfelfing, Germany.
PharmaSGP Holding SE Financial Data Overview
| 20.74 | |
| 21.31 | |
| - | |
| 20.57 | |
| 21.22 | |
| 16.6534-23.2 | |
| 252 M | |
| 13.9073 | |
| 11 990 K | |
| 107 M | |
| 0.0642 | |
| -0.002 |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
PharmaSGP Holding SE Fundamental Data is available in our Financial Data APIs
- Net Revenue 107 M
- EBITDA 35 024 K
- Earnings Per Share 1.51
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get PharmaSGP Holding SE Earnings via APIs
- Latest Release 2024-09-12
- EPS/Forecast NaN
Get PharmaSGP Holding SE End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
